These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 37706617)
21. Emerging targeted protein degradation tools for innovative drug discovery: From classical PROTACs to the novel and beyond. Zhong Y; Chi F; Wu H; Liu Y; Xie Z; Huang W; Shi W; Qian H Eur J Med Chem; 2022 Mar; 231():114142. PubMed ID: 35092900 [TBL] [Abstract][Full Text] [Related]
22. 10 years of click chemistry: synthesis and applications of ferrocene-derived triazoles. Ganesh V; Sudhir VS; Kundu T; Chandrasekaran S Chem Asian J; 2011 Oct; 6(10):2670-94. PubMed ID: 21882351 [TBL] [Abstract][Full Text] [Related]
23. PROTACs, molecular glues and bifunctionals from bench to bedside: Unlocking the clinical potential of catalytic drugs. Maneiro M; De Vita E; Conole D; Kounde CS; Zhang Q; Tate EW Prog Med Chem; 2021; 60():67-190. PubMed ID: 34147206 [TBL] [Abstract][Full Text] [Related]
24. Click and Bioorthogonal Chemistry: The Future of Active Targeting of Nanoparticles for Nanomedicines? Taiariol L; Chaix C; Farre C; Moreau E Chem Rev; 2022 Jan; 122(1):340-384. PubMed ID: 34705429 [TBL] [Abstract][Full Text] [Related]
25. Discovery of intracellular self-assembly protein degraders driven by tumor-specific activatable bioorthogonal reaction. Si R; Hai P; Zheng Y; Wang J; Zhang Q; Li Y; Pan X; Zhang J Eur J Med Chem; 2023 Sep; 257():115497. PubMed ID: 37216813 [TBL] [Abstract][Full Text] [Related]
26. Click chemistry approaches for developing carbonic anhydrase inhibitors and their applications. Angeli A; Supuran CT J Enzyme Inhib Med Chem; 2023 Jan; 38(1):2166503. PubMed ID: 36637011 [TBL] [Abstract][Full Text] [Related]
27. From mechanism to mouse: a tale of two bioorthogonal reactions. Sletten EM; Bertozzi CR Acc Chem Res; 2011 Sep; 44(9):666-76. PubMed ID: 21838330 [TBL] [Abstract][Full Text] [Related]
28. Targeted protein degrader development for cancer: advances, challenges, and opportunities. Fang Y; Wang S; Han S; Zhao Y; Yu C; Liu H; Li N Trends Pharmacol Sci; 2023 May; 44(5):303-317. PubMed ID: 37059054 [TBL] [Abstract][Full Text] [Related]
29. Inducing the Degradation of Disease-Related Proteins Using Heterobifunctional Molecules. Delport A; Hewer R Molecules; 2019 Sep; 24(18):. PubMed ID: 31500395 [TBL] [Abstract][Full Text] [Related]
35. Targeted Protein Degradation Technology and Nanomedicine: Powerful Allies against Cancer. Lin JY; Liu HJ; Wu Y; Jin JM; Zhou YD; Zhang H; Nagle DG; Chen HZ; Zhang WD; Luan X Small; 2023 May; 19(18):e2207778. PubMed ID: 36693784 [TBL] [Abstract][Full Text] [Related]
36. Are 1,4- and 1,5-disubstituted 1,2,3-triazoles good pharmacophoric groups? Massarotti A; Aprile S; Mercalli V; Del Grosso E; Grosa G; Sorba G; Tron GC ChemMedChem; 2014 Nov; 9(11):2497-508. PubMed ID: 25079879 [TBL] [Abstract][Full Text] [Related]
37. Applications of azide-based bioorthogonal click chemistry in glycobiology. Zhang X; Zhang Y Molecules; 2013 Jun; 18(6):7145-59. PubMed ID: 23783454 [TBL] [Abstract][Full Text] [Related]
38. Molecular imaging based on metabolic glycoengineering and bioorthogonal click chemistry. Yoon HY; Koo H; Kim K; Kwon IC Biomaterials; 2017 Jul; 132():28-36. PubMed ID: 28399460 [TBL] [Abstract][Full Text] [Related]
39. Click chemistry, a potent tool in medicinal sciences. Musumeci F; Schenone S; Desogus A; Nieddu E; Deodato D; Botta L Curr Med Chem; 2015; 22(17):2022-50. PubMed ID: 25895896 [TBL] [Abstract][Full Text] [Related]
40. Click chemistry in the development of PROTACs. Yang C; Tripathi R; Wang B RSC Chem Biol; 2024 Mar; 5(3):189-197. PubMed ID: 38456041 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]